CDSS module for EHRs based on FMEA (failure mode and effects analysis) of clinical guidelines

Disclaimer:- written with help of ChatGPT. 

FMEA = Failure Mode and Effects Analysis

EHR (Electronic Health Record) system that integrates FMEA insights to ensure safer, guideline-adherent patient centered asthma care. 

Here's how:

*1. Embed Clinical Decision Support (CDS):*

- Prompt doctors to *prescribe ICS* when asthma severity meets criteria.

- Alert if dose is too low/high for age/severity.

- Remind providers to *schedule follow-ups*.

*2. Workflow Checklists:*

- Use structured forms to *ensure inhaler technique is taught*.

- Include mandatory fields for *trigger assessment & avoidance advice*.

*3. Automation & Reminders:*

- Auto-generate *follow-up appointments*.

- Send *educational materials* to patients via portal.

*4. Real-Time Error Prevention:*

- Prevent prescription submission if *key steps* (e.g., patient education, dose confirmation) are skipped.

- Use color-coded *risk indicators*.

*5. Analytics Dashboard:*

- Track compliance with asthma guidelines.

- Monitor for *frequent deviations* or errors.

Such an EHR would directly address the failure modes identified in your FMEA and improve both safety and outcomes. 

Prompt - FMEA analysis of a clinical guideline for asthma

ChatGPT -

Here's an FMEA (Failure Modes and Effects Analysis) of a clinical guideline for asthma management, particularly focusing on key components like diagnosis, treatment, patient education, and follow-up. This helps identify potential failure points that could harm patient outcomes or healthcare processes.

---

FMEA for Clinical Guideline: Asthma Management

Step	Potential Failure Mode	Potential Effects of Failure	Potential Causes	Current Controls	Severity (S)	Occurrence (O)	Detection (D)	RPN (S×O×D)	Recommended Action
1. Diagnosis of asthma	Misdiagnosis (e.g., COPD mistaken for asthma)	Inappropriate treatment, poor control, adverse effects	Inadequate history, no spirometry	Clinical training, spirometry guideline	9	5	4	180	Mandatory spirometry for diagnosis; provider training
2. Severity classification	Underestimating severity	Inadequate therapy, frequent exacerbations	Poor symptom documentation, rushed consult	GINA severity criteria	8	4	3	96	Use checklists; digital decision support tools
3. Prescribing controller meds	Omission or incorrect dosage of inhaled corticosteroids (ICS)	Poor control, ER visits, exacerbation	Lack of knowledge, misinterpretation of stepwise therapy	Pharmacy check, EHR alerts	9	3	3	81	Incorporate guideline-based alerts in EMRs
4. Patient education	Inadequate inhaler technique education	Poor drug delivery, ineffective treatment	Time constraints, staff not trained	Nurse education, pamphlets	7	6	5	210	Hands-on demo + teach-back method; audit technique regularly
5. Follow-up planning	Missed or delayed follow-up	Poor long-term control, risk of severe attacks	Poor tracking, patient noncompliance	Appointment system	7	4	5	140	SMS reminders, follow-up flag in EMR
6. Emergency care plan	No written action plan for acute exacerbations	Delayed response in emergencies, hospitalization	Clinician oversight, lack of time	Verbal advice given	8	5	4	160	Mandate written action plans at diagnosis
7. Allergen/environmental control	Failure to advise on trigger avoidance	Continued exposure, symptom worsening	Lack of awareness, not assessed	Patient interview	6	4	4	96	Standard environmental history checklist

---

Key

• Severity (S): Impact of failure (1 = low, 10 = catastrophic)

• Occurrence (O): Likelihood of failure (1 = rare, 10 = frequent)

• Detection (D): Likelihood that failure is detected before harm (1 = very likely, 10 = not likely)

• RPN (Risk Priority Number): S × O × D

---

Top Priority Areas Based on RPN

1. Inhaler technique education (RPN 210)

2. Diagnosis without spirometry (RPN 180)

3. Lack of emergency action plan (RPN 160)

---

Let me know if you'd like this tailored to a specific setting (e.g., rural India, pediatric care, emergency departments), or if you want it as a PowerPoint/table PDF.